ZURA Relative Valuation
ZURA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ZURA is overvalued; if below, it's undervalued.
Historical Valuation
Zura Bio Ltd (ZURA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -4.62. The fair price of Zura Bio Ltd (ZURA) is between -- to -- according to relative valuation methord.
Relative Value
Fair Zone
-----
Current Price：5.26
Fair
-7.17
PE
1Y
3Y
5Y
0.00
EV/EBITDA
Zura Bio Ltd. (ZURA) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
-2.82
EV/EBIT
Zura Bio Ltd. (ZURA) has a current EV/EBIT of -2.82. The 5-year average EV/EBIT is -1.86. The thresholds are as follows: Strongly Undervalued below -7.13, Undervalued between -7.13 and -4.49, Fairly Valued between 0.78 and -4.49, Overvalued between 0.78 and 3.41, and Strongly Overvalued above 3.41. The current Forward EV/EBIT of -2.82 falls within the Historic Trend Line -Fairly Valued range.
0.00
PS
Zura Bio Ltd. (ZURA) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.
0.00
P/OCF
Zura Bio Ltd. (ZURA) has a current P/OCF of 0.00. The 5-year average P/OCF is -3.36. The thresholds are as follows: Strongly Undervalued below -10.09, Undervalued between -10.09 and -6.72, Fairly Valued between 0.00 and -6.72, Overvalued between 0.00 and 3.36, and Strongly Overvalued above 3.36. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
-5.89
P/FCF
Zura Bio Ltd. (ZURA) has a current P/FCF of -5.89. The 5-year average P/FCF is -4.34. The thresholds are as follows: Strongly Undervalued below -9.27, Undervalued between -9.27 and -6.81, Fairly Valued between -1.87 and -6.81, Overvalued between -1.87 and 0.59, and Strongly Overvalued above 0.59. The current Forward P/FCF of -5.89 falls within the Historic Trend Line -Fairly Valued range.
Zura Bio Ltd (ZURA) has a current Price-to-Book (P/B) ratio of 3.33. Compared to its 3-year average P/B ratio of 2.45 , the current P/B ratio is approximately 35.86% higher. Relative to its 5-year average P/B ratio of -0.08, the current P/B ratio is about -4092.31% higher. Zura Bio Ltd (ZURA) has a Forward Free Cash Flow (FCF) yield of approximately -14.83%. Compared to its 3-year average FCF yield of -15.21%, the current FCF yield is approximately -2.52% lower. Relative to its 5-year average FCF yield of -15.21% , the current FCF yield is about -2.52% lower.
3.33
P/B
Median3y
2.45
Median5y
-0.08
-14.83
FCF Yield
Median3y
-15.21
Median5y
-15.21
Competitors Valuation Multiple
The average P/S ratio for ZURA's competitors is 23705.58, providing a benchmark for relative valuation. Zura Bio Ltd Corp (ZURA) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of ZURA increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of ZURA in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is Zura Bio Ltd (ZURA) currently overvalued or undervalued?
Zura Bio Ltd (ZURA) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -4.62. The fair price of Zura Bio Ltd (ZURA) is between to according to relative valuation methord.
What is Zura Bio Ltd (ZURA) fair value?
ZURA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Zura Bio Ltd (ZURA) is between to according to relative valuation methord.
How does ZURA's valuation metrics compare to the industry average?
The average P/S ratio for ZURA's competitors is 23705.58, providing a benchmark for relative valuation. Zura Bio Ltd Corp (ZURA) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for Zura Bio Ltd (ZURA) as of Jan 08 2026?
As of Jan 08 2026, Zura Bio Ltd (ZURA) has a P/B ratio of 3.33. This indicates that the market values ZURA at 3.33 times its book value.
What is the current FCF Yield for Zura Bio Ltd (ZURA) as of Jan 08 2026?
As of Jan 08 2026, Zura Bio Ltd (ZURA) has a FCF Yield of -14.83%. This means that for every dollar of Zura Bio Ltd’s market capitalization, the company generates -14.83 cents in free cash flow.
What is the current Forward P/E ratio for Zura Bio Ltd (ZURA) as of Jan 08 2026?
As of Jan 08 2026, Zura Bio Ltd (ZURA) has a Forward P/E ratio of -7.17. This means the market is willing to pay $-7.17 for every dollar of Zura Bio Ltd’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Zura Bio Ltd (ZURA) as of Jan 08 2026?
As of Jan 08 2026, Zura Bio Ltd (ZURA) has a Forward P/S ratio of 0.00. This means the market is valuing ZURA at $0.00 for every dollar of expected revenue over the next 12 months.